Osteogenic differentiation capacity of human skeletal muscle-derived progenitor cells. - Wikidata - awgldk - TriplyDB

Osteogenic differentiation capacity of human skeletal muscle-derived progenitor cells.

Osteogenic differentiation capacity of human skeletal muscle-derived progenitor cells.

http://www.wikidata.org/entity/Q34606971

about

Platelet-Derived Growth Factor Receptor Alpha as a Marker of Mesenchymal Stem Cells in Development and Stem Cell Biology Interactions between muscle stem cells, mesenchymal-derived cells and immune cells in muscle homeostasis, regeneration and disease MiR-424-5p reversed epithelial-mesenchymal transition of anchorage-independent HCC cells by directly targeting ICAT and suppressed HCC progression Surgical Excision of Heterotopic Ossification Leads to Re-Emergence of Mesenchymal Stem Cell Populations Responsible for Recurrence.Pericytes: multitasking cells in the regeneration of injured, diseased, and aged skeletal muscle.Characterization of discrete subpopulations of progenitor cells in traumatic human extremity wounds.Genomic profiling reveals that transient adipogenic activation is a hallmark of mouse models of skeletal muscle regeneration.Pathogenesis and prevention strategies of heterotopic ossification in total hip arthroplasty: a narrative literature review and results of a survey in Germany.Evaluating Tissue-Specific Recombination in a Pdgfrα-CreERT2 Transgenic Mouse Line.MiR-630 Inhibits Endothelial-Mesenchymal Transition by Targeting Slug in Traumatic Heterotopic Ossification.Heterotopic ossification after the use of recombinant human bone morphogenetic protein-7.Roles of nonmyogenic mesenchymal progenitors in pathogenesis and regeneration of skeletal muscle.Osteogenic Differentiation Capacity of In Vitro Cultured Human Skeletal Muscle for Expedited Bone Tissue Engineering.Isolation of progenitors that exhibit myogenic/osteogenic bipotency in vitro by fluorescence-activated cell sorting from human fetal muscle.Identification and characterization of PDGFRα+ mesenchymal progenitors in human skeletal muscle.Muscle-Bone Crosstalk in Amyotrophic Lateral Sclerosis.Bedside, Benchtop, and Bioengineering: Physicochemical Imaging Techniques in Biomineralization.Influence of Bone and Muscle Injuries on the Osteogenic Potential of Muscle Progenitors: Contribution of Tissue Environment to Heterotopic Ossification.Two tissue-resident progenitor lineages drive distinct phenotypes of heterotopic ossification.Inhibition of PDGFR signaling prevents muscular fatty infiltration after rotator cuff tear in mice.Cellular players in skeletal muscle regeneration Contributions of muscle-resident progenitor cells to homeostasis and disease.Ex vivo bupivacaine treatment results in increased adipogenesis of skeletal muscle cells in the rat.ALS-associated mutation SOD1G93A leads to abnormal mitochondrial dynamics in osteocytes.Macrophage-derived oncostatin M contributes to human and mouse neurogenic heterotopic ossifications.Neurological heterotopic ossification following spinal cord injury is triggered by macrophage-mediated inflammation in muscle.Identification and differential expression of microRNAs in 1, 25-dihydroxyvitamin D3-induced osteogenic differentiation of human adipose-derived mesenchymal stem cells.Stem cells and heterotopic ossification: Lessons from animal models.Identification of differentially expressed miRNAs associated with chronic kidney disease-mineral bone disorder.Traumatic muscle fibrosis: From pathway to prevention.Circular RNA CDR1as regulates osteoblastic differentiation of periodontal ligament stem cells via the miR-7/GDF5/SMAD and p38 MAPK signaling pathway

P2860

Q26800104-BE2E1186-DD05-4566-895B-25E7007FDD12 Q26800192-4229046E-8A6C-4EA4-A6FB-368D2FCFF076 Q28393361-526BDDB8-6B77-4174-8449-5E846A870F36 Q33722361-B7739586-26E1-4B50-8BAE-A0A776D81A75 Q34201678-1C95A259-95AF-465C-B91B-3ED78FC63558 Q34662877-3ADF9D67-6AB9-4460-99F6-393D2C3034E2 Q34970578-E1CCABD0-27D4-4BAE-A385-2DF2EA6A92DD Q35566376-2BFCED4C-F0CF-4C53-A4ED-555FFC46F9B3 Q36132458-B6CE7766-5D5C-4974-84DE-378CC835DA9E Q36651240-B18C83DC-EAED-459B-A665-0FE1BCC1195A Q37590967-C1DC3D59-5311-4251-B46C-BE1393C7B8A2 Q37598995-B7DFD62A-8F66-41AC-9C67-E1CEF1D5D652 Q37624978-9A97D757-F51B-46C7-AE02-DD0B6EF05609 Q37663796-C1087E13-6982-435C-8688-6BA9BC65D4A9 Q37726150-C74C6DA4-06E9-444E-82C2-1BA758FCB9D2 Q38557126-6313D016-F4A5-49DA-B487-545DEC467A88 Q38703991-4404F93E-E751-4C03-B576-316A611C8BA6 Q39823846-F5E76D36-F523-4090-8F6A-958DC07E1132 Q40459563-CDF3715F-F0BC-4490-975E-314CBCD4D1BC Q41857486-78152E40-1842-43CD-BFF9-CEFD3524D080 Q41887477-3DC83CB2-691E-4C85-A048-374DA17E72BA Q42640875-482A9410-56CE-4CF1-B429-231E844E46E0 Q44358707-7DDAC164-83A0-4B3A-9CB4-7A7BA157C9E7 Q47655494-0E4E23F1-A6C0-4454-905B-E8720783F8DC Q47991308-38687B48-4A50-4A92-B80B-1255CD6F8F44 Q48312378-F03E6914-7126-4CCA-9B6D-4D936D2413D8 Q49213158-0ADFC401-83CD-4D2A-A30A-38AD3545030A Q50152313-30E0F416-A3D9-4085-9F25-3845D5453F6B Q52765383-2403FAF8-95E6-46A7-9288-54C753993274 Q54062963-E0056C52-25C1-4E72-ABE3-EBD78DC99E9D Q58781878-EA2B7906-7E1A-4D5A-81BE-36577EBEBAB3

P2860

Osteogenic differentiation capacity of human skeletal muscle-derived progenitor cells.

http://www.wikidata.org/entity/Q34606971

description

2013 nî lūn-bûn

@nan

2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Osteogenic differentiation capacity of human skeletal muscle-derived progenitor cells.

@ast

Osteogenic differentiation capacity of human skeletal muscle-derived progenitor cells.

@en

Osteogenic differentiation capacity of human skeletal muscle-derived progenitor cells.

@nl

type

label

Osteogenic differentiation capacity of human skeletal muscle-derived progenitor cells.

@ast

Osteogenic differentiation capacity of human skeletal muscle-derived progenitor cells.

@en

Osteogenic differentiation capacity of human skeletal muscle-derived progenitor cells.

@nl

prefLabel

Osteogenic differentiation capacity of human skeletal muscle-derived progenitor cells.

@ast

Osteogenic differentiation capacity of human skeletal muscle-derived progenitor cells.

@en

Osteogenic differentiation capacity of human skeletal muscle-derived progenitor cells.

@nl

P1433

Q34606971-9B2A812E-BBB3-4AB8-981A-CC760495B4B5

P1476

Q34606971-491B220B-7137-47DC-BF40-B28B6E0443A5

P2093

Q34606971-01CD3791-D418-4FA9-988D-4C9802247554

Q34606971-41A98713-72FB-4C72-B8AC-8E8B855BD166

Q34606971-6AEC7B93-2184-49A8-8CAC-20664CCC4877

Q34606971-8090A0E6-9A2D-4ACF-B99E-32308BD3716F

Q34606971-C4D1DD65-13BD-4CE6-A91B-DE7EAE871F5F

P2860

Q34606971-023E2D4C-C333-4D52-B7FA-53E458FD9F7B

Q34606971-0612F6CF-D906-4A3C-9CB8-9BABAC8F3E34

Q34606971-15830494-D773-42B1-97C1-929D4CCE7121

Q34606971-169BE94D-49B0-4B4D-97B2-F06FB33EB5F1

Q34606971-1FF4EAC5-8D2E-46AD-93C9-8B75D3777B87

Q34606971-3AC9E34D-E1A6-472B-A35B-5F9269C9F54B

Q34606971-45C1003D-1D5E-4E4F-83EB-0F2A0103D262

Q34606971-48C8C2A2-31DE-4E71-9EEB-D59BB175CEA2

Q34606971-4C048C0E-80F0-4D38-916B-414894C0E0F9

Q34606971-55388D3C-C434-4481-A442-C2FDE7777008

P304

Q34606971-1C9BACE9-990F-4551-9731-0A68496E07B4

P31

Q34606971-B904A854-C6BC-4889-BE40-2E47F598C5F4

P356

Q34606971-2EE4E48E-E8DE-4822-B07A-3161EF9C08D9

P407

Q34606971-AE6B3343-9DEE-4496-A751-A24A021E8409

P433

Q34606971-38334AFA-9F22-4EC7-A9E8-7227AC54CC90

P478

Q34606971-9E325A7A-4056-4810-B5E6-7194EF0DE62D

P50

Q34606971-75155AFE-D674-410C-B847-D2A1BBA0D714

Q34606971-8C08D0A7-4530-4525-9C77-076F5D2C4964

P577

Q34606971-1100D344-756B-4D16-B1A8-0591C53A7901

P5875

Q34606971-ECCB8E6A-549E-43E8-9689-93F96E662806

P698

Q34606971-743FB46A-668E-4FDC-BAAC-5FCD0387D75C

P932

Q34606971-F6CDA102-F68B-4AE3-86CA-822540328F16

P356

JOURNAL.PONE.0056641

P1433

P1476

Osteogenic differentiation capacity of human skeletal muscle-derived progenitor cells.

@en

P2093

Arihiko Kanaji

http://www.w3.org/2001/XMLSchema#string

Asami Yamaguchi

http://www.w3.org/2001/XMLSchema#string

Harumoto Yamada

http://www.w3.org/2001/XMLSchema#string

Naoki Yamamoto

http://www.w3.org/2001/XMLSchema#string

Teruyo Oishi

http://www.w3.org/2001/XMLSchema#string

P2860

A microRNA signature for a BMP2-induced osteoblast lineage commitment program

NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses

A perivascular origin for mesenchymal stem cells in multiple human organs

Co-expression of two perivascular cell markers isolates mesenchymal stem-like cells from human endometrium

Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts

The murine IRAK2 gene encodes four alternatively spliced isoforms, two of which are inhibitory

Regulation and function of NF-kappaB transcription factors in the immune system

Heterotopic bone formation after joint replacement.

Lymphocyte antigen Leu-19 as a molecular marker of regeneration in human skeletal muscle.

ILT2/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse.

P304

e56641

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0056641

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Akiyoshi Uezumi

Kunihiro Tsuchida

P577

2013-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235778526

http://www.w3.org/2001/XMLSchema#string

P698

23457598

http://www.w3.org/2001/XMLSchema#string

P932

3572948

http://www.w3.org/2001/XMLSchema#string